Cellbricks

Seed
cellbricks-therapeutics.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Mar 25, 2026
Investors Undisclosed
Decision Makers Profile Active

About Cellbricks

A tissue therapeutics company – built on DeepTech innovation – offering a scalable solution to restore lost tissue and organ function for millions of patients.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cellbricks.

Funding History

1 Round
Seed equity · Mar 25, 2026

Founders & Leadership

3

Alexander Leutner

Co-CEO (Business) & Co-founder

Work email & phone locked Unlock →

Alexander Thomas

Soft Tissue Program Lead & Co-founder

Work email & phone locked Unlock →

Tobias Lam

CTO & Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts